Sign up now to have the right to view
10 tenders for free.
Contract Details
| Title |
Medicinal Products Containing Ponatinib, Ibrutinib, Idelalisib Czech Republic
|
|---|---|
| Country | |
| Language | English |
| Organization | |
| Published Date | 06.02.2024 |
| Awarded Date | 16.08.2022 |
| Overview | Contract Award's Details : Medicinal Products Containing Ponatinib, Ibrutinib, Idelalisib INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION PRAGUE Medicinal Products Containing Ponatinib, Ibrutinib, Idelalisib Document Type: Contract Award Notice TITLE: Medicinal products containing ponatinib, ibrutinib, idelalisib Number Reference: VZ22036 Contract Type: Supplies Estimated Value: 55714553.35 - CZK Description: The subject of the contract is continuous supplies of medicinal products containing the active substance of ponatinib, ibrutinib and idelalisib (ATC Group L01E) in the expected quantity and composition according to the technical specifications listed in the tender documentation. 33652100 - Antineoplastic Agents Authority Type: Other Type of Procedure: Open Procedure Regulation: European Union BID Type: Not Applicable DOC TITLE: Antineoplastic Agents Dispatch Date: 2022-08-11 Publish Date: 2022-08-16 Czech Republic Contract value : 55,714,553.35 CZK Contractors : PHOENIX PHARMACY WHOLESALE, S.R.O., JANSSEN-CILAG S.R.O., GILEAD SCIENCES S.R.O. 13/07/2022 17/08/2022 01/01/1900 78538258 17/08/2022 INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION PRAGUE Address : At the Hospital 2094/1 Ing. Simona Bartonová zakazky@uhkt.cz Czech Republic Czech Republic Contract Awards Czech Republic 13/07/2022 01/01/1900 55,714,553.35 CZK |
| NAICS | |
| CPVS | |
| UNSPSC |
-
|
| Regions | |
| Sectors | |
| Contractor | |
| Contract Value |
55,714,553.35 CZK
|
URL |
| Share |
Czech Republic
| Title |
|---|
|
Medicinal Products Containing Ponatinib, Ibrutinib, Idelalisib Czech Republic
|
| Country |
| Language |
| English |
| Organization |
| Published Date |
| 06.02.2024 |
| Awarded Date |
| 16.08.2022 |
| Overview |
| Contract Award's Details : Medicinal Products Containing Ponatinib, Ibrutinib, Idelalisib INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION PRAGUE Medicinal Products Containing Ponatinib, Ibrutinib, Idelalisib Document Type: Contract Award Notice TITLE: Medicinal products containing ponatinib, ibrutinib, idelalisib Number Reference: VZ22036 Contract Type: Supplies Estimated Value: 55714553.35 - CZK Description: The subject of the contract is continuous supplies of medicinal products containing the active substance of ponatinib, ibrutinib and idelalisib (ATC Group L01E) in the expected quantity and composition according to the technical specifications listed in the tender documentation. 33652100 - Antineoplastic Agents Authority Type: Other Type of Procedure: Open Procedure Regulation: European Union BID Type: Not Applicable DOC TITLE: Antineoplastic Agents Dispatch Date: 2022-08-11 Publish Date: 2022-08-16 Czech Republic Contract value : 55,714,553.35 CZK Contractors : PHOENIX PHARMACY WHOLESALE, S.R.O., JANSSEN-CILAG S.R.O., GILEAD SCIENCES S.R.O. 13/07/2022 17/08/2022 01/01/1900 78538258 17/08/2022 INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION PRAGUE Address : At the Hospital 2094/1 Ing. Simona Bartonová zakazky@uhkt.cz Czech Republic Czech Republic Contract Awards Czech Republic 13/07/2022 01/01/1900 55,714,553.35 CZK |
| NAICS |
| Regulation Regulation |
| CPVS |
| Antineoplastic agents Dates |
| UNSPSC |
| - |
| Regions |
| Europe |
| Sectors |
| Healthcare and Medicine Automobiles and Auto Parts Supply Postal and Courier Services Law and Legal Printing and Publishing Plastic and Rubber Defence and Security Construction Agriculture-Food and Beverages Energy-Power and Electrical Computer Hardwares and Consumables |
| Contractor |
| Contract Value |
|
55,714,553.35 CZK
|
| URL |
|
|
| Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Contracts